Viewing Study NCT00614835


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2026-04-04 @ 11:30 AM
Study NCT ID: NCT00614835
Status: COMPLETED
Last Update Posted: 2015-12-22
First Post: 2008-01-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module